{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:01:01Z","timestamp":1791414061604,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1177\/1933719117728802","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T11:30:08Z","timestamp":1505907008000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial"],"prefix":"10.1007","volume":"25","author":[{"given":"Jeris","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnie","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Britten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"issue":"1","key":"2502198_CR1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obset Gynecol. 2003;188(1):100\u2013107.","journal-title":"Am J Obset Gynecol"},{"issue":"1","key":"2502198_CR2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/GRF.0000000000000171","volume":"59","author":"CB Bartels","year":"2016","unstructured":"Bartels CB, Cayton KC, Chuong FS, et al. An evidence-based approach to the medical management of fibroids: a systematic review. Clin Obstet Gynecol. 2016;59(1):30\u201352.","journal-title":"Clin Obstet Gynecol"},{"issue":"5728","key":"2502198_CR3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","volume":"308","author":"CL Walker","year":"2005","unstructured":"Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589\u20131592.","journal-title":"Science"},{"issue":"1","key":"2502198_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ogc.2005.12.004","volume":"33","author":"M Payson","year":"2006","unstructured":"Payson M, Leppert P, Segars J. Epidemiology of myomas. Obset Gynecol Clin N Am. 2006;33(1):1\u201311.","journal-title":"Obset Gynecol Clin N Am"},{"issue":"1","key":"2502198_CR5","first-page":"8","volume":"100","author":"ER Myers","year":"2002","unstructured":"Myers ER, Barber MD, Gustilo-Ashby T, Couchman G, Matchar DB, McCrory DC. Management of uterine leiomyomata: what do we really know? Obstet Gynecol. 2002;100(1):8\u201317.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2502198_CR6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","volume":"111","author":"ED Levens","year":"2008","unstructured":"Levens ED, Potlog-Nahari C, Armstrong AY, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol. 2008;111(5):1129\u20131136.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2502198_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","volume":"95","author":"LK Nieman","year":"2011","unstructured":"Nieman LK, Blocker W, Nansel T, et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase lib study. Fertil Steril. 2011;95(2):767\u2013772.","journal-title":"Fertil Steril"},{"key":"2502198_CR8","unstructured":"Nieman LK. Treatment of uterine fibroids with the selective progesterone receptor modulator CDB-2014. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00290251."},{"issue":"5","key":"2502198_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez J, Tatarchuk TF, Bouchard P, et al; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366(5):409\u2013420.","journal-title":"N Engl J Med"},{"issue":"5","key":"2502198_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","volume":"366","author":"J Donnez","year":"2012","unstructured":"Donnez J, Tomaszewski J, Vazquez F, et al; PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N EnglJ Med. 2012;366(5):421\u2013432.","journal-title":"N EnglJ Med"},{"issue":"2","key":"2502198_CR11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","volume":"103","author":"J Donnez","year":"2015","unstructured":"Donnez J, Hudecek R, Donnez O, et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril. 2015;103(2):519\u2013527.","journal-title":"Fertil Steril"},{"issue":"1","key":"2502198_CR12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fertnstert.2015.09.006","volume":"105","author":"M Malik","year":"2016","unstructured":"Malik M, Britten J, Cox J, Patel A, Catherino WH. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones. Fertil Steril. 2016;105(1):214\u2013224.","journal-title":"Fertil Steril"},{"issue":"4","key":"2502198_CR13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2015.12.021","volume":"105","author":"A Patel","year":"2016","unstructured":"Patel A, Malik M, Britten J, Cox J, Catherino WH. Mifepristone inhibits extracellular matrix formation in uterine leiomyoma. Fer-til Steril. 2016;105(4):1102\u20131110.","journal-title":"Fer-til Steril"},{"key":"2502198_CR14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fphar.2015.00315","volume":"6","author":"E Rosato","year":"2016","unstructured":"Rosato E, Farris M, Bastianelli C. Mechanism of action of ulipristal acetate for emergency contraception: a systematic review. Front Pharmacol. 2016;6:315.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2502198_CR15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","volume":"195","author":"PC Leppert","year":"2006","unstructured":"Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obset Gynecol. 2006;195(2):415\u2013420.","journal-title":"Am J Obset Gynecol"},{"issue":"3","key":"2502198_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","volume":"28","author":"M Malik","year":"2010","unstructured":"Malik M, Norian J, McCarthy-Keith D, Britten J, Catherino WH. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Sent Reprod Med. 2010;28(3):169\u2013179.","journal-title":"Sent Reprod Med"},{"issue":"3","key":"2502198_CR17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","volume":"28","author":"N Chegini","year":"2010","unstructured":"Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28(3):180\u2013203.","journal-title":"Semin Reprod Med"},{"issue":"12","key":"2502198_CR18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","volume":"16","author":"JM Norian","year":"2009","unstructured":"Norian JM, Malik M, Parker CY, et al. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci. 2009;16(12):1153\u20131164.","journal-title":"Reprod Sci"},{"issue":"3","key":"2502198_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12079-014-0234-x","volume":"8","author":"C Fujisawa","year":"2014","unstructured":"Fujisawa C, Castellot J Jr. Matrix production and remodeling as therapeutic targets for uterine leiomyoma. J Cell Commun Signal. 2014;8(3):179\u2013194.","journal-title":"J Cell Commun Signal"},{"issue":"3","key":"2502198_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","volume":"14","author":"Q Xu","year":"2008","unstructured":"Xu Q, Ohara N, Liu J, et al. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells. Mol Hum Reprod. 2008;14(3):181\u2013191.","journal-title":"Mol Hum Reprod"},{"issue":"9","key":"2502198_CR21","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","volume":"21","author":"Q Xu","year":"2006","unstructured":"Xu Q, Ohara N, Chen W, et al. Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells. Hum Reprod. 2006;21(9):2408\u20132416.","journal-title":"Hum Reprod"},{"issue":"2","key":"2502198_CR22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2004-1569","volume":"90","author":"Q Xu","year":"2005","unstructured":"Xu Q, Takekida S, Ohara N, et al. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bc1-2 protein expression and up-regulates caspase-3 and poly(adenosine 5\u2019-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab. 2005;90(2):953\u2013961.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2502198_CR23","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.fertnstert.2006.08.111","volume":"87","author":"M Malik","year":"2007","unstructured":"Malik M, Catherino WH. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays. Fertil Steril. 2007;87(5):1166\u20131172.","journal-title":"Fertil Steril"},{"issue":"2","key":"2502198_CR24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.fertnstert.2008.06.030","volume":"92","author":"M Pay son","year":"2009","unstructured":"Pay son M, Malik M, Siti-Nur Morris S, Segars JH, Chason R, Catherino WH. Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development. Fertil Steril. 2009;92(2):748\u2013755.","journal-title":"Fertil Steril"},{"issue":"9","key":"2502198_CR25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1177\/1933719114545240","volume":"21","author":"M Malik","year":"2014","unstructured":"Malik M, Britten J, Segars J, Catherino WH. Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fas-udil, a rho-kinase inhibitor, when compared to 2-dimensional cultures. Reprod Sci. 2014;21(9):1126\u20131138.","journal-title":"Reprod Sci"},{"issue":"2","key":"2502198_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2004-828614","volume":"22","author":"W Catherino","year":"2004","unstructured":"Catherino W, Salama A, Potlog-Nahari C, Leppert P, Tsibris J, Segars J. Gene expression studies in leiomyomata: new directions for research. Semin Reprod Med. 2004;22(2):83\u201390.","journal-title":"Semin Reprod Med"},{"issue":"3","key":"2502198_CR27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1933719115607994","volume":"23","author":"NM Barker","year":"2016","unstructured":"Barker NM, Carrino DA, Caplan Al, et al. Proteoglycans in leiomyoma and normal myometrium: abundance, steroid hormone control, and implications for pathophysiology. Reprod Sci. 2016;23(3):302\u2013309.","journal-title":"Reprod Sci"},{"key":"2502198_CR28","first-page":"2013","volume":"528376","author":"GP Flake","year":"2013","unstructured":"Flake GP, Moore AB, Sutton D, et al. The natural history of uterine leiomyomas: light and electron microscopic studies of fibroid phases, interstitial ischemia, inanosis, and reclamation. Obstet Gynecol Int. 2013;2013:528376.","journal-title":"Obstet Gynecol Int"},{"issue":"5","key":"2502198_CR29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","volume":"96","author":"P Bouchard","year":"2011","unstructured":"Bouchard P, Chabbert-Buffet N, Fauser B. Selective progeter-one receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety. Fertil Steril. 2011;96(5):1175\u20131189.","journal-title":"Fertil Steril"},{"issue":"7","key":"2502198_CR30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425255.2012.695775","volume":"8","author":"GB Melis","year":"2012","unstructured":"Melis GB, Piras B, Marotto MF, et al. Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment. Expert Opin Drug Metab Toxicol. 2012;8(7):901\u2013908.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"2502198_CR31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","volume":"26","author":"K Chwalisz","year":"2005","unstructured":"Chwalisz K, Perez MC, DeManno D, Winkel C, Schubert G, Elger W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev. 2005;26(3):423\u2013438.","journal-title":"Endocr Rev"},{"issue":"2","key":"2502198_CR32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","volume":"104","author":"GE Courtoy","year":"2015","unstructured":"Courtoy GE, Donnez J, Marbaix E, Dolmans MM. In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment. Fertil Steril. 2015;104(2):426\u2013434.el.","journal-title":"Fertil Steril"},{"issue":"11","key":"2502198_CR33","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/molehr\/3.11.1005","volume":"3","author":"Q Dou","year":"1997","unstructured":"Dou Q, Tarnuzzer RW, Williams RS, Schultz GS, Chegini N. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression. Mol Hum Reprod. 1997;3(11):1005\u20131014.","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"2502198_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/107155769800500408","volume":"5","author":"SS Palmer","year":"1998","unstructured":"Palmer SS, Haynes-Johnson D, Diehl T, Nowak RA. Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J Soc Gynecol Investig. 1998;5(4):203\u2013209.","journal-title":"J Soc Gynecol Investig"},{"issue":"9","key":"2502198_CR35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/09513590701557416","volume":"23","author":"M Bogusiewicz","year":"2007","unstructured":"Bogusiewicz M, Stryjecka-Zimmer M, Postawski K, Jakimiuk AJ, Rechberger T. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium. Gynecol Endocrinol. 2007;23(9):541\u2013546.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"2502198_CR36","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1515\/cclm-2014-0798","volume":"53","author":"P Korompelis","year":"2015","unstructured":"Korompelis P, Piperi C, Adamopoulos C, et al. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas. Clin Chem Lab Med. 2015;53(9):1415\u20131424.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2502198_CR37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000077177","volume":"58","author":"M Wolahska","year":"2004","unstructured":"Wolahska M, Sobolewski K, Bahkowski E, Jaworski S. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. Gynecol Obstet Invest. 2004;58(1):14\u201318.","journal-title":"Gynecol Obstet Invest"},{"issue":"9","key":"2502198_CR38","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/humrep\/det265","volume":"28","author":"SK Haider","year":"2013","unstructured":"Haider SK, Osteen KG. Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013;28(9):2407\u20132416.","journal-title":"Hum Reprod"},{"issue":"2","key":"2502198_CR39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","volume":"7","author":"M Giannandrea","year":"2014","unstructured":"Giannandrea M, Parks WC. Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014;7(2):193\u2013203.","journal-title":"Dis Model Mech"},{"issue":"8","key":"2502198_CR40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","volume":"4","author":"WC Parks","year":"2004","unstructured":"Parks WC, Wilson CL. Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004;4(8):617\u2013629.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2502198_CR41","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.092134099","volume":"99","author":"F Zuo","year":"2002","unstructured":"Zuo F, Kaminski N, Eugui E, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A. 2002;99(9):6292\u20136297.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2502198_CR42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14(2):163\u2013176.","journal-title":"Genes Dev"},{"issue":"22","key":"2502198_CR43","doi-asserted-by":"crossref","first-page":"13763","DOI":"10.1074\/jbc.M114.622274","volume":"290","author":"C Dayer","year":"2015","unstructured":"Dayer C, Stamenkovic I. Recruitment of matrix metalloproteinase-9 (MMP-9) to the fibroblast cell surface by lysyl hydroxylase 3 (LH3) triggers transforming growth factor-P (TGF-P) activation and fibroblast differentiation. J Biol Chem. 2015;290(22):13763\u201313778.","journal-title":"J Biol Chem"},{"issue":"9","key":"2502198_CR44","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1177\/1933719114542019","volume":"21","author":"P Ciarmela","year":"2014","unstructured":"Ciarmela P, Carrarelli P, Islam MS, et al. Ulipristal acetate modulates the expression and functions of activin a in leiomyoma cells. Reprod Sci. 2014;21(9):1120\u20131125.","journal-title":"Reprod Sci"},{"issue":"7","key":"2502198_CR45","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.fertnstert.2011.03.084","volume":"95","author":"D McCarthy-Keith","year":"2011","unstructured":"McCarthy-Keith D, Malik M, Britten J, Segars J, Catherino W. Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells. Fertil Steril. 2011;95(7):2383\u20132387.","journal-title":"Fertil Steril"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719117728802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719117728802","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719117728802\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719117728802","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719117728802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719117728802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T02:02:29Z","timestamp":1656813749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719117728802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2502198"],"URL":"https:\/\/doi.org\/10.1177\/1933719117728802","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"1 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}